Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Allied Chemicals Pharmaceuticals Pvt Ltd

    Allied Chemicals & Pharmaceuticals Pvt. Ltd. was incorporated in 1965 has its manufacturing plant in Jaipur - where it manufactures, generics and proprietary medicines since 1

  • No Image
    Alpa Laboratories Ltd

    Alpa Laboratories Ltd is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber, about 15 kilometers from the city of Indore in Central India. Alpa Laboratories has

  • No Image
    Alpha Pharma Healthcare

    Alpha-Pharma Healthcare India has recently commissioned a allopathic pharmaceutical unit in Murbad village in MIDC in Thane dte of Maharashtra. The plant has a capacity of 10 Mi

  • No Image
    Ambica Chemicals

    Ambica Chemicals (AC) was established during 1989 as a proprietorship firm by Mr Amrutlal N Chaudhari to undertake trading activity of pharma intermediates. Currently, the firm

  • No Image
    Ami Lifesciences Pvt Ltd

    Ami group was established in the 1997 by Mr. Girish Chovatia to cater the pharmaceutical market with a vision to be globally focused.

    In the year 2002 company acquired i